TAK logo

TAK Net Income

Annual Net Income

$998.37 M
-$1.35 B-57.47%

March 31, 2024


Summary


Performance

TAK Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTAKprofitabilitymetrics:

Quarterly Net Income

$155.96 M
-$463.73 M-74.83%

December 1, 2024


Summary


Performance

TAK Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTAKprofitabilitymetrics:

TTM Net Income

$1.37 B
-$560.04 M-29.07%

December 1, 2024


Summary


Performance

TAK TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTAKprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TAK Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.5%-74.8%-29.1%
3 y3 years-71.8%-33.8%-41.6%
5 y5 years-18.1%-91.6%-61.5%

TAK Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-71.8%at low-81.5%+146.9%-66.2%+40.3%
5 y5-year-71.8%+145.3%-91.6%+146.9%-69.1%+924.5%
alltimeall time-71.8%+174.9%-91.6%+108.2%-69.1%+206.2%

Takeda Pharmaceutical Company Limited Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-
$155.96 M(-74.8%)
$1.37 B(-29.1%)
Sep 2024
-
$619.69 M(+1.4%)
$1.93 B(+97.7%)
Jun 2024
-
$611.00 M(-3104.7%)
$974.15 M(-4.0%)
Mar 2024
$998.37 M(-57.5%)
-$20.33 M(-102.8%)
$1.01 B(-20.2%)
Dec 2023
-
$716.00 M(-315.3%)
$1.27 B(-9.2%)
Sep 2023
-
-$332.51 M(-151.0%)
$1.40 B(-35.8%)
Jun 2023
-
$651.48 M(+176.4%)
$2.18 B(-6.8%)
Mar 2023
$2.35 B(+14.6%)
$235.71 M(-72.1%)
$2.34 B(+16.6%)
Dec 2022
-
$844.99 M(+89.1%)
$2.00 B(+20.2%)
Sep 2022
-
$446.94 M(-44.9%)
$1.67 B(+1.8%)
Jun 2022
-
$810.45 M(-929.0%)
$1.64 B(-21.4%)
Mar 2022
$2.05 B(-42.2%)
-$97.77 M(-119.2%)
$2.09 B(-48.4%)
Dec 2021
-
$508.19 M(+21.7%)
$4.04 B(-8.5%)
Sep 2021
-
$417.60 M(-66.8%)
$4.42 B(+9.4%)
Jun 2021
-
$1.26 B(-32.4%)
$4.04 B(+13.8%)
Mar 2021
$3.55 B(+771.4%)
$1.86 B(+110.4%)
$3.55 B(+108.2%)
Dec 2020
-
$884.32 M(+2224.8%)
$1.70 B(+225.2%)
Sep 2020
-
$38.04 M(-95.0%)
$524.31 M(-53.1%)
Jun 2020
-
$766.76 M(+4743.6%)
$1.12 B(+169.5%)
Mar 2020
$407.05 M(-66.6%)
$15.83 M(-105.3%)
$414.73 M(+211.0%)
Dec 2019
-
-$296.32 M(-146.9%)
$133.36 M(-82.6%)
Sep 2019
-
$631.45 M(+890.2%)
$764.66 M(+34.7%)
Jun 2019
-
$63.77 M(-124.0%)
$567.68 M(-53.5%)
Mar 2019
$1.22 B(-27.7%)
-$265.54 M(-179.3%)
$1.22 B(+23.6%)
Dec 2018
-
$334.98 M(-22.9%)
$988.47 M(-21.3%)
Sep 2018
-
$434.46 M(-39.4%)
$1.26 B(+16.9%)
Jun 2018
-
$717.36 M(-243.9%)
$1.07 B(-35.3%)
Mar 2018
$1.69 B(+58.7%)
-$498.34 M(-182.7%)
$1.66 B(-3.0%)
Dec 2017
-
$602.88 M(+138.6%)
$1.71 B(+15.0%)
Sep 2017
-
$252.69 M(-80.6%)
$1.49 B(+0.7%)
Jun 2017
-
$1.30 B(-392.1%)
$1.48 B(+34.8%)
Mar 2017
$1.06 B(+59.1%)
-$446.18 M(-217.7%)
$1.10 B(-12.4%)
Dec 2016
-
$379.13 M(+56.6%)
$1.25 B(-8.0%)
Sep 2016
-
$242.03 M(-73.7%)
$1.36 B(-0.1%)
Jun 2016
-
$921.53 M(-417.1%)
$1.36 B(+111.7%)
Mar 2016
$668.06 M
-$290.57 M(-159.6%)
$643.85 M(-167.2%)
Dec 2015
-
$487.84 M(+100.0%)
-$958.34 M(-25.5%)
DateAnnualQuarterlyTTM
Sep 2015
-
$243.92 M(+20.4%)
-$1.29 B(+2.0%)
Jun 2015
-
$202.66 M(-110.7%)
-$1.26 B(+10.9%)
Mar 2015
-$1.33 B(-225.2%)
-$1.89 B(-1282.3%)
-$1.14 B(-328.1%)
Dec 2014
-
$160.09 M(-40.7%)
$497.98 M(-43.5%)
Sep 2014
-
$269.75 M(-17.5%)
$880.89 M(-15.6%)
Jun 2014
-
$326.95 M(-226.3%)
$1.04 B(-3.4%)
Mar 2014
$1.06 B(-40.8%)
-$258.81 M(-147.7%)
$1.08 B(-25.2%)
Dec 2013
-
$543.00 M(+25.4%)
$1.44 B(+27.0%)
Sep 2013
-
$432.93 M(+18.9%)
$1.14 B(+2.1%)
Jun 2013
-
$363.96 M(+246.6%)
$1.11 B(-39.5%)
Mar 2013
$1.80 B(+14.3%)
$105.01 M(-55.4%)
$1.84 B(+44.2%)
Dec 2012
-
$235.50 M(-42.5%)
$1.28 B(-6.4%)
Sep 2012
-
$409.84 M(-62.5%)
$1.36 B(-21.0%)
Jun 2012
-
$1.09 B(-337.4%)
$1.73 B(+10.6%)
Mar 2012
$1.57 B(-45.4%)
-$460.05 M(-242.7%)
$1.56 B(-35.3%)
Dec 2011
-
$322.37 M(-58.3%)
$2.42 B(-18.3%)
Sep 2011
-
$772.91 M(-16.6%)
$2.96 B(-5.1%)
Jun 2011
-
$926.65 M(+135.4%)
$3.12 B(+8.0%)
Mar 2011
$2.88 B(-10.3%)
$393.59 M(-54.4%)
$2.89 B(-1.1%)
Dec 2010
-
$863.04 M(-7.4%)
$2.92 B(+3.2%)
Sep 2010
-
$931.84 M(+33.8%)
$2.83 B(+4.0%)
Jun 2010
-
$696.69 M(+63.8%)
$2.72 B(-14.4%)
Mar 2010
$3.21 B(+36.1%)
$425.27 M(-45.0%)
$3.18 B(-8.1%)
Dec 2009
-
$773.75 M(-6.1%)
$3.46 B(-6.4%)
Sep 2009
-
$824.17 M(-28.7%)
$3.70 B(+5.0%)
Jun 2009
-
$1.16 B(+64.2%)
$3.52 B(+48.9%)
Mar 2009
$2.36 B(-24.4%)
$703.69 M(-30.4%)
$2.36 B(+42.4%)
Dec 2008
-
$1.01 B(+56.3%)
$1.66 B(+156.3%)
Sep 2008
-
$647.15 M
$647.15 M
Mar 2008
$3.12 B(+8.6%)
-
-
Mar 2007
$2.87 B(+3.7%)
-
-
Mar 2006
$2.77 B(+7.2%)
-
-
Mar 2005
$2.59 B(+2.1%)
-
-
Mar 2004
$2.53 B(+13.4%)
-
-
Mar 2003
$2.23 B(+18.3%)
-
-
Mar 2002
$1.89 B(+41.8%)
-
-
Mar 2001
$1.33 B(+23.4%)
-
-
Mar 2000
$1.08 B
-
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual net profit?
  • What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly net profit?
  • What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
  • What is Takeda Pharmaceutical Company Limited TTM net profit?
  • What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?

What is Takeda Pharmaceutical Company Limited annual net profit?

The current annual net income of TAK is $998.37 M

What is the all time high annual net income for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual net profit is $3.55 B

What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?

Over the past year, TAK annual net profit has changed by -$1.35 B (-57.47%)

What is Takeda Pharmaceutical Company Limited quarterly net profit?

The current quarterly net income of TAK is $155.96 M

What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly net profit is $1.86 B

What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?

Over the past year, TAK quarterly net profit has changed by -$463.73 M (-74.83%)

What is Takeda Pharmaceutical Company Limited TTM net profit?

The current TTM net income of TAK is $1.37 B

What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high TTM net profit is $4.42 B

What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?

Over the past year, TAK TTM net profit has changed by -$560.04 M (-29.07%)